WASHINGTON – Following an increase in the trafficking and abuse of novel psychoactive substances (NPS) throughout the United States, the Drug Enforcement Administration has emergency scheduled bromazolam, a synthetic benzodiazepine used to make counterfeit Xanax tablets. The emergency scheduling of bromazolam places it into Schedule I under the Controlled Substances...

ALEXANDRIA, Va. – Sebastian Enrique Marset Cabrera, 34, an alleged cocaine trafficker from Uruguay, made his initial appearance in federal court today on charges relating to his alleged role in a money laundering conspiracy. Marset was added to the DEA’s Most Wanted Fugitive List in May 2025. Court documents alleged...

WASHINGTON – Today, the U.S. Drug Enforcement Administration, with the cooperation of the U.S. Attorney’s Office for the Eastern District of New York, announced the seizure of more than 200 website domains tied to an India-based transnational criminal organization (TCO) working within the United States and allegedly responsible for at...

WASHINGTON – 2025 was a year of historic achievements for the U.S. Drug Enforcement Administration highlighted by significant drug seizures, the capture of high-profile targets, and the confirmation of DEA Administrator Terrance C. Cole. Appointed by President Donald Trump on February 11, 2025 and sworn in on July 23, 2025...

The United States announced today that yesterday evening it took into custody 37 fugitives from Mexico facing a range of federal criminal charges around the country, including charges relating to narcoterrorism, providing material support to a foreign terrorist organization, firearms trafficking, human smuggling, money laundering, and various drug trafficking offenses...

WASHINGTON – This week the U.S. Drug Enforcement Administration released the established aggregate production quotas (APQ) for schedule I and II controlled substances and assessment of annual needs (AAN) for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine for 2026. “DEA is committed to ensuring that patients can access the...

WASHINGTON – The U.S. Drug Enforcement Administration, in partnership with the Department of Health and Human Services (HHS), has issued a Fourth Temporary Extension of the COVID-19 Telemedicine Flexibilities for the Prescription of Controlled Medications , extending the current telemedicine flexibilities through December 31, 2026. Under these telemedicine flexibilities, DEA-registered...

WASHINGTON –The Drug Enforcement Administration, in collaboration with nearly 4,000 law enforcement partners across the country, will host the 29th National Prescription Drug Take Back Day this Saturday, October 25, from 10 a.m. to 2 p.m. At nearly 4,000 collection sites throughout the United States, DEA’s National Prescription Drug Take...

WASHINGTON – Today, the Drug Enforcement Administration announced the results of a week-long operational surge aimed at dismantling the Jalisco New Generation Cartel (CJNG), one of the most violent and prolific drug trafficking organizations in the world. Designated as a Foreign Terrorist Organization in February by the Trump Administration, CJNG...

WASHINGTON – Today, the Drug Enforcement Administration announced the results of a week-long operational enforcement action as part of a whole-of-government initiative aimed at removing dangerous and illegal vaping substances from communities across America. During the operation, DEA seized more than 2.3 million vape devices and cartridges and more than...